Berman Capital Advisors’s BioLife Solutions BLFS Stock Holding History

Berman Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$0	Hold	8	–	–	﹤0.01%	2071
2021 Q2	$0	Buy	+8	New	+$282	﹤0.01%	1898

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Berman Capital Advisors's BLFS Position: Q3 2021 in Review

Berman Capital Advisors held its BioLife Solutions (BLFS) position steady in Q3 2021 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

Berman Capital Advisors first reported a position in BLFS in Q2 2021 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

Berman Capital Advisors held 8 shares of BioLife Solutions worth $0 as of Q3 2021.
Berman Capital Advisors left its BioLife Solutions share count unchanged in Q3 2021.
BioLife Solutions made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2071 holding.
Berman Capital Advisors first reported a position in BioLife Solutions in Q2 2021 and has held it in 2 quarters since.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.